Array
(
[1579858050] => Array
(
[wpseo_ping_search_engines] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1579858773] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1579859281] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1579860752] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1579860911] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579860952] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579867952] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579872726] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1579873474] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579873799] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[9c17b652013c0cb178fd59d7d59f09a2] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1579873799
)
)
)
)
[1579879073] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1579882024] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579885011] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579936112] => Array
(
[ai1wm_storage_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1579942171] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1580009352] => Array
(
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1580132999] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[5ada2658dd6ca5445c1cf45e314bad7b] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1580132999
)
)
)
)
[1580137200] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1580169600] => Array
(
[publish_future_post] => Array
(
[2d492587fa52e9c78f7043ddf937b0a1] => Array
(
[schedule] =>
[args] => Array
(
[0] => 18611
)
)
[dea3edad73162f380bc9dc44fa3407bf] => Array
(
[schedule] =>
[args] => Array
(
[0] => 19670
)
)
[2caa9c58a241c4f77a6856802c1b43fb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 20734
)
)
[307b37ba29b8cd716eafa809661756e3] => Array
(
[schedule] =>
[args] => Array
(
[0] => 22852
)
)
[365be9eba8e62abb0c0d4bfe013a2687] => Array
(
[schedule] =>
[args] => Array
(
[0] => 23918
)
)
[0e942b20ffb9550322105263ad82126f] => Array
(
[schedule] =>
[args] => Array
(
[0] => 24977
)
)
[661c5eb39689fe2133ff7986ac6628fb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 26036
)
)
[75562b264e355915e4dea97042a28f7e] => Array
(
[schedule] =>
[args] => Array
(
[0] => 27095
)
)
[11cf4e8a6f842b0115881551a29c47f6] => Array
(
[schedule] =>
[args] => Array
(
[0] => 28154
)
)
[55a38aaca11da398c854cb29a7d4f5e6] => Array
(
[schedule] =>
[args] => Array
(
[0] => 30272
)
)
[f8cbc904676c235c7057ec965c01c023] => Array
(
[schedule] =>
[args] => Array
(
[0] => 32390
)
)
)
)
[1583794819] => Array
(
[publish_future_post] => Array
(
[9d993985746691420cd7524448c48a23] => Array
(
[schedule] =>
[args] => Array
(
[0] => 448880
)
)
)
)
[1601157627] => Array
(
[publish_future_post] => Array
(
[aa3f9c41dd8e97586795881a0c603b8d] => Array
(
[schedule] =>
[args] => Array
(
[0] => 472787
)
)
)
)
)
Etiquetas: Autoridades competentes, Barcelona, Comisión Europea, Consejos, Donante, Donante cadáver, Donante vivo, Evaluación de la conformidad, Fundació Puigvert, Intervención quirúrgica, Lista de Espera, Lluís Guirado, Novartis, Organismos Notificados, Órganos, Posoperatorio, Rechazo, recomendaciones, salud, Sanidad, Tejidos, Trasplante renal, Trasplates, Unidad de Transplante Renal.
Etiquetas: Año 2011, Benchmarking, Buenas prácticas, Coordinación hospitalaria, Donación, Donación de órganos, Donante, efectividad, Guía, Guía de buenas prácticas, Madrid, ONT, Organización Nacional de Trasplantes, Perfil idóneo, posible donante, Proceso de donación, Proceso de la Donación de Órganos, Rafael Matesanz, Recomendacicones, salud, Sanidad.
Etiquetas: Albacete, Alerta, Alta, Castilla la Mancha, Centro coordinador de trasplantes, Complicaciones, Donante, Fármacos inmunosupresores, Historia, Intervención quirúrgica, Jose Mª Díaz Borrego, Lista de Espera, Manual, Manual del paciente, Mª del Mar Sánchez Soria, Mª José Sánchez Carretero, Paciente, Precauciones, Preparación antes del transplante, Programa de trasplante, salud, Sanidad, SESCAM, Transporte, Trasplante, trasplantes, Vida cotidiana.
Etiquetas: 7 febrero 2007, 7/02/2007, Acción farmacológica, Agencia Europea de Medicamentos, Autorización de comercialización, Bruselas, Células animales, Células humanas, Citoblastos embrionarios, Comisión de Asuntos Jurídicos, Comisión de Medio Ambiente, Comité de terapias avanzadas, Consejo sobre medicamentos de terapia avanzada, Directiva, Donante, EMEA, Enfermedades humanas, Enmiendas, Evaluación de datos, Fabricación, Farmacovigilancia, Funciones fisiológicas, Genoterapia, Hiltrud Breyer, Incentivos, informe, Ingeniería tisular, Inmunológica, Medicamentos biológicos, Medicamentos de terapia avanzada, Medicamentos para uso humano, Medicos, Metabólica, Miroslav Mikolášik, pacientes, Parlamento Europeo, Pequeñas y medianas empresas, Prevenir, Prevenir enfermedades humanas, Producto sanitario, PYME, Receptor, Reglamentación de los medicamentos, salud, Salud pública, Sanidad, Seguridad Alimentaria, Tejidos, Terapia celular somática, Tratado CE, Tratar.
Utilizamos cookies propias y de terceros para recopilar información que ayuda a optimizar su visita. Las cookies no se utilizan para recoger información de carácter personal. Usted puede permitir su uso o rechazarlo, también puede cambiar su configuración siempre que lo desee. Al continuar con la navegación entendemos que se acepta nuestra política de cookies.
x.gif)